ActiTrexx (private company)
See something wrong or missing? Let us know
Offices:Mainz
Industry:BiotechHealth services
Business model:B2B
ActiTrexx has developed a cellular therapy with activated regulatory T cells ( ATreg) to minimize the high risk of rejection after stem cell transplantation.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 4.18M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to ActiTrexx
Name | Criteria | |
---|---|---|
![]() |
APIM Therapeutics
57%
|
|
![]() |
Sano Genetics
57%
|
|
![]() |
SonoClear
57%
|
|
![]() |
Adapttech
57%
|
|
![]() |
Molecule.one
57%
|
|
![]() |
Clustermarket
57%
|
|
![]() |
Sarcura
53%
|
|
![]() |
Scailyte
53%
|
|
![]() |
Synklino
53%
|
|
![]() |
CellulaREvolution
53%
|
|